Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression

NCT03606395 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment Resistant Depression

Interventions

DRUG: NV-5138
DRUG: Placebos

Sponsor

Navitor Pharmaceuticals, Inc.